A randomized trial of dihydroartemisinin–piperaquine versus artemether–lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali

BACKGROUND: Artemether–lumefantrine (AL) and artesunate–amodiaquine are first-line treatment for uncomplicated malaria in many endemic countries, including Mali. Dihydroartemisinin–piperaquine (DHA–PQ) is also an alternative first-line artemisinin-based combination therapy, but only few data are ava...

Descripción completa

Detalles Bibliográficos
Autores principales: Dama, Souleymane, Niangaly, Hamidou, Djimde, Moussa, Sagara, Issaka, Guindo, Cheick Oumar, Zeguime, Amatigue, Dara, Antoine, Djimde, Abdoulaye A., Doumbo, Ogobara K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173860/
https://www.ncbi.nlm.nih.gov/pubmed/30290808
http://dx.doi.org/10.1186/s12936-018-2496-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173860/
https://www.ncbi.nlm.nih.gov/pubmed/30290808
http://dx.doi.org/10.1186/s12936-018-2496-x

Ejemplares similares